MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

TRDA is expected to report earnings to rise 8.51% to -101 cents per share on May 07

Entrada Therapeutics TRDA Stock Earnings Reports
Q1'26
Est.
$-1.02
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
The last earnings report on February 26 showed earnings per share of -93 cents, beating the estimate of -98 cents. With 134.09K shares outstanding, the current market capitalization sits at 519.52M.
View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on February 26, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com